4//SEC Filing
Moore Yan 4
Accession 0000899243-22-004131
CIK 0001850838other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:05 PM ET
Size
5.5 KB
Accession
0000899243-22-004131
Insider Transaction Report
Form 4
Moore Yan
Chief Medical Officer
Transactions
- Award
Option (Right to Buy)
2022-01-31+477,715→ 477,715 totalExercise: $11.36Exp: 2032-01-30→ Common Stock (477,715 underlying)
Footnotes (1)
- [F1]The options vest and become exercisable as to 25% on January 3, 2023 and as to 6.25% of the underlying shares upon the Reporting Person's completion of each three full months of continued service to the Issuer thereafter, such that the option will be fully vested and exercisable on January 3, 2026.
Documents
Issuer
Omega Therapeutics, Inc.
CIK 0001850838
Entity typeother
Related Parties
1- filerCIK 0001901999
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 4:05 PM ET
- Size
- 5.5 KB